| Nov 1 |
Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024
|
| Oct 24 |
Qualigen Therapeutics announces CEO and CFO retirements
|
| Sep 20 |
Qualigen Therapeutics received extension from Nasdaq hearings panel
|
| Sep 20 |
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
|
| Sep 6 |
Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
|
| Sep 6 |
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
|
| Sep 5 |
Gold Moves Higher; Science Applications International Posts Upbeat Earnings
|
| Sep 5 |
Qualigen Therapeutics stock falls after it prices $3.46M public offering
|
| Sep 5 |
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering
|
| Jul 16 |
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
